Diabetic retinopathy (DR) is an important cause of avoidable blindness worldwide. Seventy percent of diabetes occur in low and lower-middle income countries. Clinical practice guidelines for the ...

"Empagliflozin could be beneficial in slowing down progression to more advanced stages of diabetic ... (mean age 65.6, 52.4% men, 75% white). For the diabetic retinopathy progression analysis ...

Many diabetic retinopathy patients don't experience noticeable vision changes until the condition progresses significantly. Many diabetic retinopathy patients don’t experience noticeable vision ...

Background: This study was performed to assess the prevalence of dry eye syndrome and diabetic retinopathy (DR) in type 2 diabetic patients and their contributing factors. Methods: 199 type 2 ...

Patients with diabetic retinopathy need special care while pregnant, according to a speaker at Retina 2025. Irena Tsui, MD, said hormonal, metabolic and vascular changes during pregnancy can lead to ...

Considering taking supplements to treat diabetic retinopathy? Below is a list of common natural remedies used to treat or reduce the symptoms of diabetic retinopathy. Follow the links to read ...

The implementation of AIDRSS offers transformative implications for DR screening in India, particularly in rural and ...

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading the Flagship-founded biotech to drop the candidate.

The phase 1 clinical trial is a multicenter, open-label, dose-escalation study to assess drug safety via intravitreal ...